Detalhe da pesquisa
1.
Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry.
Br J Clin Pharmacol
; 90(5): 1301-1311, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38369687
2.
Evaluation of genetic variants associated with the risk of thiopurine-related pancreatitis: a case control study from ENEIDA registry.
Dig Dis
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38452742
3.
Hepatosplenic T-cell lymphoma and inflammatory bowel disease.
Rev Esp Enferm Dig
; 116(3): 175-176, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37170572
4.
Incidence of herpes zoster in patients with inflammatory bowel disease. / Incidencia de herpes zóster en pacientes con enfermedad inflamatoria intestinal: estudio observacional y retrospectivo en dos hospitales españoles de tercer nivel.
Gastroenterol Hepatol
; 47(6): 598-604, 2024.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38316174
5.
Recommendations on the management of severe obesity in patients with inflammatory bowel disease of the Spanish Group on Crohn's Disease and Ulcerative Colitis (GETECCU), Spanish Society of Obesity (SEEDO), Spanish Association of Surgery (AEC) and Spanish Society of Digestive Endoscopy (SEED). / Recomendaciones sobre el manejo de la obesidad grave en pacientes con enfermedad inflamatoria intestinal del Grupo Español de Trabajo en Enfermedad Inflamatoria Intestinal (GETECCU), Sociedad Española de Obesidad (SEEDO), Asociación Española de Cirugía (AEC) y Sociedad Española de Endoscopia Digestiva (SEED).
Gastroenterol Hepatol
; 2024 Jan 28.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38290648
6.
Combination of granulocyte-monocyte apheresis and tofacitinib: Multicentre and retrospective study.
Gastroenterol Hepatol
; 2024 Jan 23.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38266817
7.
Combinación de granulocito-monocito aféresis y ustekinumab: estudio multicéntrico y retrospectivo.
Gastroenterol Hepatol
; : 502195, 2024 May 04.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38710466
8.
Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU.
Am J Gastroenterol
; 118(6): 1036-1046, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36516073
9.
Mesalazine dose modification based on faecal calprotectin levels in patients with ulcerative colitis in clinical remission. / Modificación de la dosis de mesalazina en función de los niveles de calprotectina fecal en pacientes con colitis ulcerosa en remisión clínica.
Gastroenterol Hepatol
; 2023 Oct 06.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-37806344
10.
Impact of left atrial appendage closure in patients on anticoagulation for atrial fibrillation and recurrent or chronic gastrointestinal bleeding.
Gastroenterol Hepatol
; 46(8): 621-627, 2023 Oct.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-36828118
11.
Clinical and endoscopic outcomes of patients with colonic Crohn's disease treated with 5-aminosalicylates as monotherapy.
Gastroenterol Hepatol
; 46(3): 164-170, 2023 Mar.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-36179946
12.
Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease on Biological Agents During the SARS-CoV-2 Pandemic.
Dig Dis Sci
; 66(12): 4191-4196, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33469807
13.
Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease.
Aging Clin Exp Res
; 33(8): 2355-2359, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34164799
14.
Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents.
J Gastroenterol Hepatol
; 35(12): 2080-2087, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32350906
15.
Spacing the Administration Interval of Anti-TNF Agents: A Valid Strategy for Patients with Inflammatory Bowel Disease?
Dig Dis Sci
; 65(7): 2036-2043, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31858325
16.
Impact of pain associated with the subcutaneous administration of adalimumab.
Gastroenterol Hepatol
; 43(1): 9-13, 2020 Jan.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-31492425
17.
Granulocyte-monocyte apheresis: an alternative combination therapy after loss of response to anti-TNF agents in ulcerative colitis.
Scand J Gastroenterol
; 54(4): 459-464, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30982369
18.
Nivolumab-induced immune-mediated colitis: an ulcerative colitis look-alike-report of new cases and review of the literature.
Int J Colorectal Dis
; 34(5): 861-865, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30826963
19.
Recurrent skin reaction at the site of former subcutaneous injection after switching back to intravenous vedolizumab.
Gastroenterol Hepatol
; 47(4): 377-378, 2024 Apr.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-37399941
20.
Perception of the impact of intravenous biological treatment on the work and professional environment in patients with inflammatory bowel disease.
Gastroenterol Hepatol
; : 502193, 2024 May 07.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38723767